Identification Generic Name (1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE DrugBank Accession Number DB08244 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE (DB08244) ×  Close Weight Average: 354.3931  Monoisotopic: 354.154369682  Chemical Formula C 21 H 20 F 2 N 2 O Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Kinesin-like protein KIF11 Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as alpha amino acid amides. These are amide derivatives of alpha amino acids. Kingdom Organic compounds Super Class Organic acids and derivatives Class Carboxylic acids and derivatives Sub Class Amino acids, peptides, and analogues Direct Parent Alpha amino acid amides Alternative Parents Phenylpyrrolines  /  Fluorobenzenes  /  Aryl fluorides  /  Tertiary carboxylic acid amides  /  Pyrroles  /  Azacyclic compounds  /  Organopnictogen compounds  /  Organofluorides  /  Organic oxides  /  Monoalkylamines  /  Hydrocarbon derivatives  /  Carbonyl compounds 
 
 
  show 2 more Substituents 2-phenylpyrroline  /  Alpha-amino acid amide  /  Amine  /  Aromatic heteromonocyclic compound  /  Aryl fluoride  /  Aryl halide  /  Azacycle  /  Benzenoid  /  Carbonyl group  /  Carboxamide group  /  Fluorobenzene  /  Halobenzene  /  Hydrocarbon derivative  /  Monocyclic benzene moiety  /  Organic nitrogen compound  /  Organic oxide  /  Organic oxygen compound  /  Organofluoride  /  Organohalogen compound  /  Organoheterocyclic compound  /  Organonitrogen compound  /  Organooxygen compound  /  Organopnictogen compound  /  Primary aliphatic amine  /  Primary amine  /  Pyrrole  /  Pyrroline  /  Tertiary carboxylic acid amide 
 
 
  show 18 more Molecular Framework Aromatic heteromonocyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key VCOUEHUEFUDZIS-PMACEKPBSA-N InChI InChI=1S/C21H20F2N2O/c22-16-8-9-18(23)17(11-16)15-10-19(13-4-2-1-3-5-13)25(12-15)21(26)20(24)14-6-7-14/h1-5,8-11,14,19-20H,6-7,12,24H2/t19-,20-/m0/s1 IUPAC Name (2S)-2-amino-2-cyclopropyl-1-[(2S)-4-(2,5-difluorophenyl)-2-phenyl-2,5-dihydro-1H-pyrrol-1-yl]ethan-1-one SMILES [H][C@](N)(C1CC1)C(=O)N1CC(=C[C@@]1([H])C1=CC=CC=C1)C1=CC(F)=CC=C1F References General References Not Available External Links PubChem Compound 6102824 PubChem Substance 99444715 ChemSpider 4810325 BindingDB 24060 ChEMBL CHEMBL204459 ZINC ZINC000013982540 PDBe Ligand N4T PDB Entries 2fl2 Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.00884 mg/mL ALOGPS logP 3.04 ALOGPS logP 3.43 Chemaxon logS -4.6 ALOGPS pKa (Strongest Basic) 8.49 Chemaxon Physiological Charge 1 Chemaxon Hydrogen Acceptor Count 2 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 46.33 Å 2 Chemaxon Rotatable Bond Count 4 Chemaxon Refractivity 96.75 m 3 ·mol -1 Chemaxon Polarizability 36.48 Å 3 Chemaxon Number of Rings 4 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 1.0 Blood Brain Barrier + 0.9789 Caco-2 permeable - 0.5172 P-glycoprotein substrate Substrate 0.5434 P-glycoprotein inhibitor I Non-inhibitor 0.6269 P-glycoprotein inhibitor II Non-inhibitor 0.8606 Renal organic cation transporter Non-inhibitor 0.6468 CYP450 2C9 substrate Non-substrate 0.8622 CYP450 2D6 substrate Non-substrate 0.7897 CYP450 3A4 substrate Substrate 0.5172 CYP450 1A2 substrate Inhibitor 0.6991 CYP450 2C9 inhibitor Inhibitor 0.5935 CYP450 2D6 inhibitor Non-inhibitor 0.834 CYP450 2C19 inhibitor Inhibitor 0.6677 CYP450 3A4 inhibitor Inhibitor 0.7632 CYP450 inhibitory promiscuity High CYP Inhibitory Promiscuity 0.927 Ames test Non AMES toxic 0.6085 Carcinogenicity Non-carcinogens 0.8798 Biodegradation Not ready biodegradable 0.9972 Rat acute toxicity 2.6861 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9923 hERG inhibition (predictor II) Inhibitor 0.8434    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more Binding Properties × Property Measurement pH Temperature (°C) References IC 50 (nM) 2 N/A N/A A30281 
 
 
  Details 
 
 
   Binding Properties 1.  Kinesin-like protein KIF11 Kind Protein Organism Humans Pharmacological action Unknown General Function Protein kinase binding Specific Function Motor protein required for establishing a bipolar spindle. Blocking of KIF11 prevents centrosome migration and arrest cells in mitosis with monoastral microtubule arrays. Gene Name KIF11 Uniprot ID P52732 Uniprot Name Kinesin-like protein KIF11 Molecular Weight 119158.025 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:30 / Updated at June 12, 2020 16:52 